NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Vedanta Share Price Jumps as NCLAT Hearing Looms

Vedanta share price surged over 4% on Tuesday ahead of the National Company Law Appellate Tribunal (NCLAT) hearing on the Jaiprakash Associates insolvency case. The company's shares gained as much as 4.17% to ₹718.80 apiece on the BSE.

The Delhi bench of the NCLAT will hear Vedanta's appeal challenging the approval of the resolution plan for Jaiprakash Associates Limited (JAL) on April 10. The Supreme Court had declined to stay the implementation of the Adani group's ₹14,535-crore bid to acquire the debt-ridden JAL, but provided a safeguard by restraining the firm's monitoring committee from taking any "major policy decisions" without prior nod of the NCLAT.

BidderAmount (₹ crore)
Adani Enterprises14,535
Vedanta17,926

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The top court asked the NCLAT to decide the plea and the counter petition expeditiously by hearing them on an "out of turn basis" on the dispute over the acquisition of JAL by the Adani group. Vedanta has maintained that it was formally communicated as the highest bidder, both on substantive terms and on a net present value (NPV) basis.

Vedanta's resolution plan, pegged at ₹17,926 crore, offers a significantly higher value than the ₹14,535 crore proposed by the other bidder. The company has contended that its resolution plan would result in an additional recovery of about ₹3,400 crore for creditors. Vedanta sought an expedited hearing on April 10, urging the tribunal to take up the matter at the earliest.

At 10:50 AM, Vedanta share price was trading 3.66% higher at ₹715.25 apiece on the BSE. The outcome of the upcoming hearing is likely to have significant implications for the competing bidders, including Vedanta Limited, as well as for creditors awaiting recovery and the IBC's broader objective of time-bound resolution under India's insolvency framework.

Investor Takeaway

Investors should monitor the NCLAT hearing on April 10 for potential impact on Vedanta's share price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.